MktsMarkets
Eli Lilly and Company
NYSE: LLYKey statistics
LLY News
Stories mentioning LLY from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 19,799,000 | 19,291,500 | 17,600,800 | 15,557,700 | 12,729,000 | 13,533,100 | 11,439,100 | 11,302,800 |
| Cost of Goods Sold | 3,577,000 | 3,370,900 | 3,008,300 | 2,447,800 | 2,225,000 | 2,403,500 | 2,170,800 | 2,170,200 |
| Gross Profit | 16,222,000 | 15,920,600 | 14,592,500 | 13,109,900 | 10,504,000 | 11,129,600 | 9,268,300 | 9,132,600 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 2,934,000 | 3,132,300 | 2,740,700 | 2,753,000 | 2,468,000 | 2,424,700 | 2,099,800 | 2,117,300 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 65,000 | 40,000 | 48,300 | 44,300 | 47,800 | 37,300 | ||
| Interest Expense | ||||||||
| Other Expense | (179,400) | (101,000) | (3,500) | (25,500) | (20,900) | (7,800) | ||
| Pretax Income | 8,850,000 | 8,266,200 | 7,232,400 | 6,776,400 | 3,456,000 | 5,038,300 | 1,588,400 | 3,517,200 |
| Tax Provision | 1,454,000 | 1,628,200 | 1,649,900 | 1,115,900 | 697,000 | 628,500 | 618,100 | 550,200 |
| Net Income (Loss) | 7,396,000 | 6,638,000 | 5,582,500 | 5,660,500 | 2,759,000 | 4,409,800 | 970,300 | 2,967,000 |
| Earnings Per Share (Basic) | 8.27 | 7.40 | 6.22 | 6.30 | 3.07 | 4.90 | 1.08 | 3.29 |
| Earnings Per Share (Diluted) | 8.26 | 7.38 | 6.21 | 6.29 | 3.06 | 4.88 | 1.07 | 3.28 |
| Weighted Average Shares Outstanding (Basic) | 894,500 | 897,300 | 896,900 | 897,900 | 898,700 | 900,600 | 901,000 | 900,900 |
| Weighted Average Shares Outstanding (Diluted) | 895,900 | 899,300 | 898,800 | 899,800 | 900,600 | 904,100 | 905,000 | 904,200 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LLY
Eli Lilly and Company (NYSE: LLY) is a stock listed on the New York Stock Exchange under the ticker symbol LLY. It last traded at $1,257.03 (Oct 16, 2026, 4:00 PM ET), up 0.4% on the day. That gives Eli Lilly and a market capitalisation of $1.17T and a price-to-earnings ratio of 43.9.
Over the past 52 weeks LLY has traded between $783.85 and $1,292.65.
Revenue for the quarter ended Mar 31, 2026 was $19.8B; net income $7.4B. Revenue was up 55.5% from $12.7B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $19.8B | $7.4B | 37.4% |
| Dec 31, 2025 | $19.3B | $6.6B | 34.4% |
| Sep 30, 2025 | $17.6B | $5.6B | 31.7% |
| Jun 30, 2025 | $15.6B | $5.7B | 36.4% |
From Eli Lilly and’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…